Cancer has affected us all in some form or fashion. This can be either directly or indirectly. This devastating disease has claimed the lives of millions throughout the years, but there has been plenty of remarkable discoveries along the way. Cancer research is big business, and it has made it possible to get a better prognosis of the disease. Seattle Genetics, an oncology biotech company, has a firm-grip on how to effectively deal with some forms of the disease. Located in Bothell, Washington, this company specializes in developing and commercialization antibody-based conjugates. These cancer-fighting medications are some of the best in the business. Antibody-based conjugates will attach themselves directly to cancerous cells within the body, and it will deliver a cell-killing blow.
Dr. Clay Siegall is the captain of the ship, and he has more than 30 years of experience. This amazing man is known to be a scientist, a doctor, a philanthropist and an author. He has an undergraduate degree in Biology from the University of Maryland as well as a Ph.D in Genetics from George Washington University. Recent reports from the National Cancer Institute has stated that 40 percent of both men and women will receive a cancer-diagnosis in their lifetime. The medications of today are far superior than the medications of the past. Radboud MC Hospital in Holland has been able to diagnose cancer a faster rate than any other organization. This is huge because the disease won’t have time to manifest if the person’s taking the medications to eradicate the disease when it commences.
Instead of having to wait months, this new diagnosis will only take a few weeks. The innovative ultrasound-scan testing is making huge waves throughout the industry, and it is giving patients a clearer report of the illness itself. As you can see, this only scratches the surface of what’s been going on. Technological-advancements and research is the name of the game and Dr. Clay Siegall epitomizes this notion to the highest degree.